Drug-to-Antibody Ratio (DAR) Calculation of Antibody-Drug Conjugates (ADCs)

An Integrated Workflow for Automated Calculation of Antibody‑Drug Conjugate (ADC) Drug‑to-Antibody Ratio (DAR) Using Automated Sample Preparation, Agilent MassHunter Walkup, and Agilent MassHunter BioConfirm DAR Calculator Software Application Note Biotherapeutics and Biosimilars Authors Abstract David L. Wong, Tanner Stevenson, and…

Analysis of Antibody Drug Conjugate Through the Characterization of Drug Antibody Ratios Using an Agilent 1290 Infinity Binary LC System Coupled to an Agilent 6550 iFunnel Q-TOF Application Note Biopharma Authors Introduction Ravindra Gudihal and Jing Chen Antibody drug conjugates…

Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum Using Automated Affinity Purification, LC/MS analysis, and Novel DAR Calculation Software Application Note Authors Introduction Jing Chen, Michael Bovee, and Antibody-drug conjugates (ADCs) are an emerging class of biotherapeutics designed…

Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes Application compendium Contents Introduction3 Featured application notes 2 PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mAbs and ADC (5991-7163EN) 5 Intact- and Peptide-Level Characterization of Trastuzumab Emtansine In Vitro…